THE Therapeutic Goods Administration has confirmed that changes to the regulatory framework for advertising of therapeutic goods will begin this month, with a two year implementation period.
The new regime includes enhanced sanctions and penalties for addressing non-compliant advertising, along with an amended Therapeutic Goods Advertising Code which will become effective from 01 Jul 2018.
Also from that same date a streamlined complaints handling system will be implemented, with a single body responsible for handling complaints about the advertising of therapeutic goods.
The regulations will see the abolition of the requirement for certain advertisements to be pre-approved from 01 Jul 2020.
A formal education program, including guidance materials, will be developed and implemented to support advertisers, along with transition arrangements with the Complaints Resolution Panel.
The TGA said the changes reflect the recommendations of the Review of Medicines and Medical Devices Regulation - tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 18
